Alzheimer's Drug Discovery Foundation (ADDF)
The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
Introduction détaillée
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
PlusRecherche
JSTOR
JSTOR is a digital library providing access to a vast collection of academic journals, books, and primary sources across various disciplines, facilitating research and education worldwide.
Erickson Foundation - Advancing Psychological Development and Wellness
The Erickson Foundation is a non-profit organization dedicated to advancing psychological development and wellness. We support individuals and families through research, education, and community services to promote mental health and social well-being.
Institute of Psychology | University of Innsbruck
The Institute of Psychology at the University of Innsbruck offers a comprehensive range of programs and research opportunities in psychology. It hosts various events, seminars, and conferences, fostering a vibrant academic community.